Concepedia

Lynn Rich

LR

Statistics

Publications

4

Citations

356

H-Index

4

Active since

2008

Affiliations

University of Rochester Medical Center(Current)

University of Rochester

Lynn Rich is an author at University of Rochester Medical Center specializing in cancer immunotherapy, lymphoid neoplasms, and rituximab-based therapy.

Publications per year

2008–2011

4

Publications

4

The combination of bendamustine, bortezomib, and rituximab for patients with relapsed/refractory indolent and mantle cell non-Hodgkin lymphoma

Jonathan W. Friedberg, Julie M. Vose, Jennifer L. Kelly et al. · Blood · 2011 · 192 citations · Full text

, , +14

Phase II study of a TLR‐9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma

Jonathan W. Friedberg, Jennifer L. Kelly, Donna Neuberg et al. · British Journal of Haematology · 2009 · 80 citations · Full text

, , +17

Bortezomib and gemcitabine in relapsed or refractory Hodgkin's lymphoma

Jason H. Mendler, Jennifer L. Kelly, Susan Voci et al. · Annals of Oncology · 2008 · 43 citations · Full text

, , +12

Profound Hypogammaglobulinemia 7 Years after Treatment for Indolent Lymphoma

Alison R. Walker, Anatole Kleiner, Lynn Rich et al. · Cancer Investigation · 2008 · 41 citations

, , +17

1–4 of 4